tiprankstipranks
Trending News
More News >
Athira Pharma (ATHA)
NASDAQ:ATHA
US Market
Advertisement

Athira Pharma (ATHA) Technical Analysis

Compare
555 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Athira Pharma’s (ATHA) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Athira Pharma is a Sell.
Athira Pharma’s (ATHA) 20-Day exponential moving average is 0.39, while Athira Pharma’s (ATHA) share price is $0.4, making it a Buy.
Athira Pharma’s (ATHA) 50-Day exponential moving average is 0.38, while Athira Pharma’s (ATHA) share price is $0.4, making it a Buy.

Athira Pharma (ATHA) Pivot Points

Aug 28, 2025, 07:10 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.36
0.37
0.39
0.40
0.41
0.42
0.43
Fibonacci
0.37
0.38
0.39
0.40
0.41
0.41
0.42
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Athira Pharma (ATHA) Moving Averages

Aug 28, 2025, 07:10 PM
Period
Simple
Exponential
MA5
0.40Buy
0.40Sell
MA10
0.40Buy
0.40Buy
MA20
0.39Buy
0.39Buy
MA50
0.38Buy
0.38Buy
MA100
0.33Buy
0.37Buy
MA200
0.42Sell
0.44Sell
Athira Pharma’s (ATHA) 10-Day exponential moving average is 0.40, while Athira Pharma’s (ATHA) share price is $0.4, making it a Buy.
Athira Pharma’s (ATHA) 100-Day exponential moving average is 0.37, while Athira Pharma’s (ATHA) share price is $0.4, making it a Buy.
Athira Pharma’s (ATHA) stock price is $0.4 and Athira Pharma’s (ATHA) 50-day simple moving average is 0.38, creating a Buy signal.
Athira Pharma’s (ATHA) stock price is $0.4 and Athira Pharma’s (ATHA) 100-day simple moving average is 0.33, creating a Buy signal.
Athira Pharma’s (ATHA) stock price is $0.4 and Athira Pharma’s (ATHA) 200-day simple moving average is 0.42, creating a Sell signal.

Athira Pharma (ATHA) Technical Indicators

Aug 28, 2025, 07:10 PM
Name
Value
Implied Action
RSI (14)
53.22
Neutral
STOCH (9,6)
74.56
Neutral
STOCHRSI (14)
78.53
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
11.93
Buy
Williams %R
-34.21
Buy
CCI (14)
79.58
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
63.08
Neutral
ROC
8.11
Buy
Athira Pharma’s (ATHA) Relative Strength Index (RSI) is 53.22, creating a Neutral signal.
Athira Pharma’s (ATHA) Trend Strength Indicator (ADX) is 11.93, creating a Buy signal.
Athira Pharma’s (ATHA) Commodity Channel Index (CCI) is 79.58, creating a Neutral signal.
Athira Pharma’s (ATHA) Price Rate of Change (ROC) is 8.11, creating a Buy signal.

FAQ

Is ATHA a Buy, Hold, or Sell?
Based on ATHA’s technical indicators, ATHA is a Buy.
    What is ATHA’s RSI (14)?
    ATHA’s RSI (14) is 53.22, which suggests ATHA is a Neutral.
      What is ATHA’s MACD?
      ATHA’s MACD is <0.01, which suggests ATHA is a Sell.
        What is ATHA’s 5-day moving average?
        ATHA’s 5-day moving average is 0.40, which suggests ATHA is a Buy.
          What is ATHA’s 20-day moving average?
          ATHA 20-day moving average is 0.39, which suggests ATHA is a Buy.
            What is ATHA’s 50-day moving average?
            ATHA’s 50-day moving average is 0.38, which suggests ATHA is a Buy.
              What is ATHA’s 200-day moving average?
              ATHA’s 200-day moving average is 0.42, which suggests ATHA is a Sell.
                What is ATHA’s Williams % R (14)?
                ATHA’s Williams % R (14) is -34.21, which suggests ATHA is a Buy.
                  What is ATHA’s CCI (14)?
                  ATHA’s CCI (14) is 79.58, which suggests ATHA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis